injectable OX2 agonist

Ph. I candidate for narcolepsy

from HTS and optimization

ACS Med. Chem. Lett.


injectable OX2 agonist - Takeda

Context. Danavorexton (Takeda, TAK-925) is a CNS-penetrant, injectable OX2 agonist. Orexin receptor (OX1/OX2) antagonists (e.g. daridorexant) are approved for treatment of insomnia. Orexin agonism would be expected to have…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: